GSK on Tuesday unveiled a lawsuit filed against Moderna in Delaware federal court, alleging that its patented inventions ...

Jazz Pharmaceuticals announced Tuesday that adding its small cell lung cancer drug Zepzelca to a maintenance treatment ...

Immusoft gave a glimpse on Monday at how the first patient to ever receive an engineered B cell therapy is doing nine months ...

MeiraGTx unveiled results from a small dataset for its Parkinson’s disease gene therapy on Tuesday morning, causing its ...

Johnson & Johnson cut a handful of trials across its portfolio in the third quarter, including a Phase 2 study of a touted ...

Pfizer is deepening its investment in protein degraders through a new partnership with Triana Biomedicines, a startup working ...

Walgreens is closing 1,200 stores, or 14% of its locations, as it fights to turn around its business. The retail pharmacy ...

Johnson & Johnson beat investors’ expectations despite its medtech unit underperforming, with execs pointing to the Asia-Pacific region as a continued source of struggle. Executives said on the ...

Protein production company Nuclera has raised a $75 million Series C to bring its manufacturing platform to market next ...

Stem cell biologist William Rust has been quietly working on a cure for diabetes for more than a decade. Later this year, ...

Tolerance Bio has launched with an oversubscribed $17.2 million seed round and a goal to develop therapies for ...

Dutch biotech investor Forbion has raised two new funds to put into biotech companies, just 18 months after its last major ...